These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

449 related items for PubMed ID: 8921100

  • 1. Progesterone alone versus progesterone combined with HCG as luteal support in GnRHa/HMG induced IVF cycles: a randomized clinical trial.
    Mochtar MH, Hogerzeil HV, Mol BW.
    Hum Reprod; 1996 Aug; 11(8):1602-5. PubMed ID: 8921100
    [Abstract] [Full Text] [Related]

  • 2. Human chorionic gonadotrophin is a better luteal support than progesterone in ultrashort gonadotrophin-releasing hormone agonist/menotrophin in-vitro fertilization cycles.
    Golan A, Herman A, Soffer Y, Bukovsky I, Caspi E, Ron-El R.
    Hum Reprod; 1993 Sep; 8(9):1372-5. PubMed ID: 8253920
    [Abstract] [Full Text] [Related]

  • 3. The benefits of mid-luteal addition of human chorionic gonadotrophin in in-vitro fertilization using a down-regulation protocol and luteal support with progesterone.
    Herman A, Raziel A, Strassburger D, Soffer Y, Bukovsky I, Ron-El R.
    Hum Reprod; 1996 Jul; 11(7):1552-7. PubMed ID: 8671503
    [Abstract] [Full Text] [Related]

  • 4. Luteal phase support for assisted reproduction cycles.
    van der Linden M, Buckingham K, Farquhar C, Kremer JA, Metwally M.
    Cochrane Database Syst Rev; 2011 Oct 05; (10):CD009154. PubMed ID: 21975790
    [Abstract] [Full Text] [Related]

  • 5. Luteal phase support in in-vitro fertilization using gonadotrophin releasing hormone analogue before ovarian stimulation: a prospective randomized study of human chorionic gonadotrophin versus intramuscular progesterone.
    Claman P, Domingo M, Leader A.
    Hum Reprod; 1992 Apr 05; 7(4):487-9. PubMed ID: 1522190
    [Abstract] [Full Text] [Related]

  • 6. Luteal phase support in assisted reproduction cycles.
    Daya S, Gunby J.
    Cochrane Database Syst Rev; 2004 Apr 05; (3):CD004830. PubMed ID: 15266541
    [Abstract] [Full Text] [Related]

  • 7. Effect of HCG-day serum progesterone and oestradiol concentrations on pregnancy outcomes in GnRH agonist cycles.
    Wu Z, Li R, Ma Y, Deng B, Zhang X, Meng Y, Chen X, Liu P, Qiao J.
    Reprod Biomed Online; 2012 May 05; 24(5):511-20. PubMed ID: 22417667
    [Abstract] [Full Text] [Related]

  • 8. WITHDRAWN: Luteal phase support in assisted reproduction cycles.
    Daya S, Gunby JL.
    Cochrane Database Syst Rev; 2008 Jul 16; (3):CD004830. PubMed ID: 18646113
    [Abstract] [Full Text] [Related]

  • 9. Triggering of ovulation in human menopausal gonadotrophin-stimulated cycles: comparison between intravenously administered gonadotrophin-releasing hormone (100 and 500 micrograms), GnRH agonist (buserelin, 500 micrograms) and human chorionic gonadotrophin (10,000 IU).
    Gerris J, De Vits A, Joostens M, Van Royen E.
    Hum Reprod; 1995 Jan 16; 10(1):56-62. PubMed ID: 7745071
    [Abstract] [Full Text] [Related]

  • 10. Daily low-dose hCG stimulation during the luteal phase combined with GnRHa triggered IVF cycles without exogenous progesterone: a proof of concept trial.
    Andersen CY, Elbaek HO, Alsbjerg B, Laursen RJ, Povlsen BB, Thomsen L, Humaidan P.
    Hum Reprod; 2015 Oct 16; 30(10):2387-95. PubMed ID: 26209535
    [Abstract] [Full Text] [Related]

  • 11. Towards an optimal luteal support modality in agonist triggered cycles: a randomized clinical trial.
    Elgindy EA, Sibai H, Mostafa MI, Gibreel A, Darwish E, Maghraby H.
    Hum Reprod; 2018 Jun 01; 33(6):1079-1086. PubMed ID: 29562260
    [Abstract] [Full Text] [Related]

  • 12. Luteal phase support and severe ovarian hyperstimulation syndrome.
    McClure N, Leya J, Radwanska E, Rawlins R, Haning RV.
    Hum Reprod; 1992 Jul 01; 7(6):758-64. PubMed ID: 1500471
    [Abstract] [Full Text] [Related]

  • 13. Differential effects of gonadotrophin-releasing hormone agonists administered as desensitizing or flare protocols on hormonal function in the luteal phase of hyperstimulated cycles.
    Norman RJ, Warnes GM, Wang X, Kirby CA, Matthews CD.
    Hum Reprod; 1991 Feb 01; 6(2):206-13. PubMed ID: 1905309
    [Abstract] [Full Text] [Related]

  • 14. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment.
    Beckers NG, Macklon NS, Eijkemans MJ, Ludwig M, Felberbaum RE, Diedrich K, Bustion S, Loumaye E, Fauser BC.
    J Clin Endocrinol Metab; 2003 Sep 01; 88(9):4186-92. PubMed ID: 12970285
    [Abstract] [Full Text] [Related]

  • 15. Effect of disruption versus continuation of gonadotrophin-releasing agonist after human chorionic gonadotrophin administration on corpus luteum function in patients undergoing ovulation induction for in-vitro fertilization.
    Valbuena D, Pellicer A, Guanes PP, Remohí J, Simón C.
    Hum Reprod; 1997 Oct 01; 12(10):2118-22. PubMed ID: 9402265
    [Abstract] [Full Text] [Related]

  • 16. Hormonal profiles in successful and unsuccessful implantation in IVF-ET after combined GnRH agonist/gonadotropin treatment for superovulation and hCG luteal support.
    Balasch J, Creus M, Fábregues F, Carmona F, Casamitjana R, Peñarrubia J, Rivera F, Vanrell JA.
    Gynecol Endocrinol; 1995 Mar 01; 9(1):51-8. PubMed ID: 7793300
    [Abstract] [Full Text] [Related]

  • 17. The exogenous progesterone-free luteal phase: two pilot randomized controlled trials in IVF patients.
    Humaidan P, Alsbjerg B, Elbaek HO, Povlsen BB, Laursen RJ, Jensen MB, Mikkelsen AT, Thomsen LH, Kol S, Haahr T.
    Reprod Biomed Online; 2021 Jun 01; 42(6):1108-1118. PubMed ID: 33931371
    [Abstract] [Full Text] [Related]

  • 18. Ratio of oestradiol concentration on the day of human chorionic gonadotrophin administration to mid-luteal oestradiol concentration is predictive of in-vitro fertilization outcome.
    Sharara FI, McClamrock HD.
    Hum Reprod; 1999 Nov 01; 14(11):2777-82. PubMed ID: 10548621
    [Abstract] [Full Text] [Related]

  • 19. GnRH agonist plus vaginal progesterone for luteal phase support in ICSI cycles: a randomized study.
    Aboulghar MA, Marie H, Amin YM, Aboulghar MM, Nasr A, Serour GI, Mansour RT.
    Reprod Biomed Online; 2015 Jan 01; 30(1):52-6. PubMed ID: 25456166
    [Abstract] [Full Text] [Related]

  • 20. Comparison of LH concentrations in the early and mid-luteal phase in IVF cycles after treatment with HMG alone or in association with the GnRH antagonist Cetrorelix.
    Tavaniotou A, Albano C, Smitz J, Devroey P.
    Hum Reprod; 2001 Apr 01; 16(4):663-7. PubMed ID: 11278214
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.